TIA: Updates and Management 2008
|
|
- Marcus Long
- 5 years ago
- Views:
Transcription
1 TIA: Updates and Management 2008 S. Andrew Josephson, MD Department of Neurology, Neurovascular Division University of California San Francisco Commonly Held TIA Misconceptions TIA is easy to diagnose using modern imaging modalities and laboratories TIA and stroke are distinct entities The natural history of TIA is benign Urgent treatment of TIA is of no proven benefit The speaker has no disclosures Case 1 A 67 year-old woman with a history of HTN presented to the ED after an unwitnessed 20 minute episode of left arm weakness that has since resolved. Her examination is normal. What is the most likely etiology of this spell? 1. TIA 2. Migraine 3. Partial Seizure 4. Porphyria 5. Conversion Disorder 1
2 Case 1 (con t) Within 30 minutes of the MRI, the patient experienced a witnessed spell of rhythmic shaking of the L arm followed by an extended period of paralysis. Chest X-Ray reveals large mass consistent with adenocarcinoma. Differential for Transient Focal Neurologic Deficit TIA Definition: A transient neurologic deficit attributable to a vascular cause that resolves completely within 24 hours (most are only minutes). The Big Three 1. Stroke/TIA 2. Seizure 3. Complicated Migraine Proven Markers of Migraine Motion Sickness Brain Freeze Headaches that occur at regular times related to the menstrual cycle Pain triggered by smells or repetitive noises Cyclic abdominal pain as a child Diagnosis of TIA Purely a clinical diagnosis No laboratory troponin for the brain No imaging study confirms or refutes Even experts don t agree (kappa=0.65) When in doubt, assume it is a TIA False positives are acceptable in this instance! Kraaijeveld CL Stroke
3 Case 2 A 40 year-old man with no PMH comes to the ED after a 30 minute episode of aphasia and right arm weakness that has since resolved. The patient reports 5 days of neck pain after severe vomiting from a gastroenteritis Exam is normal What is the most likely etiology of this TIA? 1. Atrial Fibrillation-Related Embolus 2. Carotid Dissection 3. Small-Vessel Atherosclerosis 4. Endocarditis 5. Hypercoagulable State UCSF Stroke Protocol CT Obtained at UCSF in all suspected acute stroke and TIA patients 1. Non-contrast CT of the head 2. CT Angiography from aortic arch/heart through Circle of Willis 3. CT Perfusion study 4. Post-contrast CT of the head MRI in TIA Diffusion-weighted MR imaging very useful in stroke to distinguish from mimics In TIA, about 50% of patients will have infarction on MRI As duration of spell increases, so does percentage with infarction But not beyond 50-60% 3
4 MRI in TIA Therefore.. 1. The distinction between TIA and stroke is quite artificial 2. MRI looking for infarction is not a useful test to exclude the diagnosis of TIA Approach to Stroke/TIA Treatment Acute Stroke Therapy? No Anticoagulants? No Antiplatelets Shrinking Indications for Anticoagulation in Stroke 1. Atrial Fibrillation 2. Some other cardioembolic sources Thrombus seen in heart?ef<35?pfo with associated Atrial Septal Aneurysm 3. Vertebral and carotid artery dissection 4. Rare hypercoagulable states: APLA Cervical Artery Dissection Vertebral and Carotid Arteries Common etiology of stroke in young Pathophysiology Risk Factors Most idiopathic Vomiting, Coughing, Chiropractic Presentation: Neck Pain, HA Tx with anticoagulation Courtesy Wade Smith, MD, PhD 4
5 Case 3 A 65 year-old man with diabetes comes to the ED after 15 minutes of L arm weakness and slurred speech that has now resolved. Vitals: BP 160/80, HR 67, sat 100%, RR 12 Exam is normal What is the approximate 90-day stroke risk for this patient? 1. 1 percent 2. 5 percent percent percent percent Risk of Future Stroke with TIA: ABCD 2 Score Age >60 =1 point Blood Pressure SBP>140 or DBP>90 =1 point Clinical Features Unilateral weakness =2 points Speech disturbance without weakness =1 point Duration >60 minutes =2 points minutes =1 point Diabetes=1 point Johnston SC, Lancet 2007 ABCD 2 Score 7-day risk overall percent 2-day risk of stroke Score 6-7: 8.1 percent (high risk) Score 4-5: 4.1 percent (moderate risk) Score 0-3: 1.0 percent (low risk) Johnston SC, Lancet
6 ABCD 2 Score: Common Sense? 1707 patients seen in the ED with TIA in Northern California before prediction rules were published Did ABCD 2 score correlate with decision to admit for further workup and treatment? No, only weak correlation (R 2 =0.036) Factors associated with admission had little relationship with factors in ABCD 2 score ABCD 2 Score: How Does It Work? The same 1707 patients seen in the ED with TIA in Northern California before prediction rules were published Expert neurologist reviewed all records retrospectively (ED and inpatient) to decide if event was a true TIA. ABCD 2 score was higher in those with true TIA Perhaps ABCD 2 partially works by identifying those with true TIA as opposed to alternative dx Josephson SA Stroke 2008 Josephson SA Stroke 2008 Appropriate TIA Workup and Treatment Imaging Workup of TIA All patients require head imaging, mainly to exclude mimics Non-contrast CT best, MR adds little value Enhanced CT/MR techniques provide further important information Vascular Imaging of Head and Neck 6
7 Vascular Imaging Utility: Case 4 A 70 year-old man with HTN, diabetes comes to the ED after 30 minutes of L arm weakness that has now resolved Large Vessel Occlusions Predict a poor outcome in Stroke and TIA patients Permissive (or induced) HTN is key in these patients to prevent further injury Likely mandates close observation Consideration should be given to intervention if the patient worsens Vascular Imaging Utility: Case 5 A 68 year-old woman with a history only of HTN presents with daily episodes of right eye blindness that completely resolve after 3 to 15 minutes. Exam is normal including fundoscopy Carotid Stenosis and TIA Along with afib, one of two etiologies of stroke/tia with the strongest evidence for intervention to prevent subsequent events Consensus guidelines urge urgent revascularization of symptomatic lesions Guidelines: After stroke, within 2 weeks TIA Experience: Within hours to days Chaturvedi S, Neurology
8 Standard TIA/Stroke Workup Cardioembolic: afib, clot in heart, paradoxical embolus 1. Telemetry 2. Echo with bubble study Aortic Arch 2. Echo with bubble study Carotids 3. Carotid Imaging (CTA, US, MRA, angio) Intracranial Vessels 4. Intracranial Imaging (CTA, MRA, angio) Case 6 A 55 year-old woman with a hx of smoking presents after 1-hour of R leg weakness that has since resolved. Her only medication at home is ASA 81mg daily. Exam is normal. And evaluate stroke risk factors What is the appropriate secondary prevention medication for this pt? 1. Coumadin 2. ASA 325mg 3. Clopidogrel (Plavix) 4. 25mg ASA/200mg ER Dipyridamole (Aggrenox) 5. Nimodipine Approach to Stroke/TIA Treatment Acute Stroke Therapy? No Anticoagulants? No Antiplatelets 8
9 Antiplatelet Options 1. ASA 50mg to 1.5g equal efficacy long-term 2. Aggrenox 25mg ASA/200mg ER Dipyridamole ESPS-2, ESPRIT (Lancet 5/06) 3. Clopidogrel (Plavix) MATCH (Lancet 7/04) FASTER (Lancet Neurol 10/07) Aggrenox vs. Plavix Aggrenox Headache in first 2 weeks: 30% discontinue Perhaps not compatible with cardiac antiplatelet goals or with unstable angina Cannot be crushed in FT Plavix Less evidence directly from stroke trials Concerns regarding use with ASA PRoFESS trial results announced May 2008 PRoFESS Trial (NEJM 9/08) Randomized, double-blind trial of Aggrenox versus Plavix in over 20,000 patients with ischemic stroke (many very minor) Recurrent 4-year event rates basically identical between the two medications HR for Aggrenox 1.01 (95% CI, ) Composite of stroke, MI, vascular death: 13.1% in each Major hemorrhagic events higher in Aggrenox group Antiplatelet Options If on no antiplatelet medication ASA or Plavix vs. Aggrenox If already on ASA Switch to Plavix vs. Aggrenox Note: There is no acute data for Aggrenox If already on Plavix or Aggrenox??? 9
10 Which of the following TIA patients are you most likely to admit? 1. 40F with DM following a 5-minute episode of aphasia 2. 85M with HTN (bp 160/90) and afib with 15 minutes of R arm weakness 3. 70M with HTN (bp 160/90), DM with 20 minutes of R leg weakness Which of the following TIA patients are you most likely to admit? 1. ABCD 2 =2 2. ABCD 2 =5 3. ABCD 2 =6 Is Urgent Evaluation of TIA Helpful or Necessary? To complete workup? To initiate secondary prevention strategies? Only for high-risk patients? To allow for t-pa to be given quickly if symptoms return? Until 2007, absolutely no evidence SOS-TIA Study: October patients with TIA admitted to a 24- hour clinic (basically an inpatient center) All treated with standard therapy 74 percent discharged on same day 90-day stroke rate reduced by 80% compared with that predicted by ABCD 2 (5.96% to 1.24%) Lavallee PC Lancet Neurology
11 EXPRESS Study: October 2007 Prospective before and after trial of patients with TIA or minor stroke Referral from ED to urgent assessment at a daily TIA clinic rather than waiting for PMD appointment Work-up completed, secondary prevention begun in clinic Reduced 90-day risk of recurrent stroke by 80% (10.3% to 2.1%, HR 0.20, 95% CI , p=0.0001) Take-Home Points TIA is a neurologic emergency Our version of unstable angina TIA is a purely clinical diagnosis If you think it s a TIA, it is The distinction between TIA and stroke is completely artificial TIA should be treated and worked up just like an ischemic stroke Rothwell PM, Lancet 2007 Take-Home Points Risk of subsequent stroke after TIA can be predicted with a high degree of accuracy Urgent evaluation and treatment of TIA patients substantially reduces this risk Whether this evaluation should occur in an inpatient setting or ultra-rapid outpatient clinic is dependent on the health care system involved 11
Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?
Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know S. Andrew Josephson, MD Director, Neurohospitalist Program Medical Director, Inpatient Neurology University
More information2015 Update in Diagnosis and Management of Stroke
2015 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Senior Executive Vice Chair, Department
More information2018 Update in Diagnosis and Management of Stroke
2018 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Chair, Department of Neurology Director,
More information2014 Update in Diagnosis and Management of Stroke
2014 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Acting Chairman, Department of Neurology
More informationSTROKE UPDATE ANTHEA PARRY MAY 2010
STROKE UPDATE ANTHEA PARRY MAY 2010 Delivery of stroke care Clinical presentations Management Health Care for London plan 8 HASU (hyperacute) units 20 stroke units TIA services Hyperacute stroke units
More informationTIA triage in Not all that glitters is gold
TIA triage in 2016 Not all that glitters is gold Disclosures No industry related disclosures Expert witness work Overview Definition Implications Guidelines, secondary prevention Implementation of guidelines
More informationStroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man
Stroke Topics Advances in the Prevention and Treatment of Stroke August 10, 2009 John W. Engstrom, M.D. Professor of Neurology Acute treatment options for ischemic stroke tpa, clot retraction, future directions
More informationSecondary Stroke Prevention
Secondary Stroke Prevention Acute stroke conference, Sunnybrook Estates January 20, 2011 Rick Swartz HBSc, MD, PhD, FRCPC Assistant Professor, Department of Medicine, Divisions of Neurology and Obstetrical
More informationCEREBRO VASCULAR ACCIDENTS
CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA
More informationTherapy for Acute Stroke. Systems of Care for TIA
Therapy for Acute Stroke and Systems of Care for TIA Gregory W. Albers, MD Coyote Foundation Professor of Neurology and Neurological Sciences Director, Stanford Stroke Center Stanford University Medical
More informationCryptogenic Strokes: Evaluation and Management
Cryptogenic Strokes: Evaluation and Management 77 yo man with hypertension and hyperlipidemia developed onset of left hemiparesis and right gaze preference, last seen normal at 10:00 AM Brought to ZSFG
More informationAlan Barber. Professor of Clinical Neurology University of Auckland
Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination pulse 80/min reg, BP 160/95
More information2/7/
Disclosure Intracranial Atherosclerosis an update None Mai N. Nguyen-Huynh, MD, MAS Assistant Professor of Neurology UCSF Neurovascular Service February 7, 2009 Case #1 60 y.o. Chinese-speaking speaking
More informationTRANSIENT ISCHEMIC ATTACK (TIA)
TRANSIENT ISCHEMIC ATTACK (TIA) AND MINOR STROKE Dr. Leanne K. Casaubon, MD MSc FRCPC Associate Professor, University of Toronto Director, TIA and Minor Stroke (TAMS) Unit University Health Network - Toronto
More informationRecent Advances in Neurology Difficult Cases
Patient X: History Part 1 Recent Advances in Neurology Difficult Cases Heather J. Fullerton, MD, MAS Professor of Neurology & Pediatrics Director, Pediatric Brain Center Previously healthy 14-year old
More informationAlan Barber. Professor of Clinical Neurology University of Auckland
Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination P 80/min reg, BP 160/95, normal
More informationCryptogenic Stroke: A logical approach to a common clinical problem
Cryptogenic Stroke: A logical approach to a common clinical problem Alphonse M. Ambrosia, DO, FACC Interventional Cardiologist CardioVascular Associates of Mesa Mesa, Arizona Speakers Bureau Boston Scientific
More information/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis
Multi-Ethnic Study of Atherosclerosis Participant ID: Hospital Code: Hospital Abstraction: Stroke/TIA History and Hospital Record 1. Was the participant hospitalized as an immediate consequence of this
More informationManagement and Investigation of Ischemic Stroke By Etiology
Management and Investigation of Ischemic Stroke By Etiology Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Deputy Dept Head, Clinical Neurosciences Heart and Stroke Foundation Chair in Stroke
More informationDavid Strain, Diabetes and Vascular Research Centre University of Exeter Medical School, UK
Risk Stratification in TIA/Stroke? David Strain, Diabetes and Vascular Research Centre University of Exeter Medical School, UK Disclaimer I would never allow a scientist to partake in my government Give
More informationKEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE
KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE Dr. Grant Stotts Staff Neurologist, Ottawa Hospital Director, Ottawa Stroke Program Medical Director, Champlain Regional Stroke Program
More informationHow do we assess risk in TIA?
How do we assess risk in TIA? David Strain, Diabetes and Vascular Research Centre University of Exeter Medical School, UK Disclaimer I would never allow a scientist to partake in my government Give them
More informationDawn Matherne Meyer PhD,RN,FNP-C. Assistant Professor University of California San Diego
Dawn Matherne Meyer PhD,RN,FNP-C Assistant Professor University of California San Diego Evidence Based Care of the Stroke Patient: A Focus on Acute Treatment, BP Management, & Antiplatelets TIME IS BRAIN
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More information[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]
2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available
More informationIntracranial Atherosclerosis in Asians
Intracranial Atherosclerosis in Asians Anthony S. Kim, MD Assistant Clinical Professor of Neurology UCSF Neurovascular Service February 27, 2010 Disclosures Research Support National Institutes of Health
More informationShawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists
Shawke A. Soueidan, MD Riverside Neurology & Sleep Specialists 757-221-0110 Epidemiology of stroke 2018 Affects nearly 800,000 people in the US annually Approximately 600000 first-ever strokes and 185000
More informationPFO Management update
PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO
More informationDisclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT
Disclosures An Update on TIA and Minor Stroke Dr. Johnston is principal investigator for the POINT trial, sponsored by the NIH but with drug and placebo contributed by Sanofi-Aventis. S. Claiborne Johnston,
More informationTRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES
TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES ALBERTO MAUD, MD ASSOCIATE PROFESSOR TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER EL PASO PAUL L. FOSTER SCHOOL OF MEDICINE 18TH ANNUAL RIO GRANDE TRAUMA 2017
More informationUnclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018
Unclogging The Pipes Zahraa Rabeeah MD Chief Resident February 9,2018 Please join Polleverywhere by texting: ZRABEEAH894 to 37607 Disclosures None Objectives Delineate the differences between TPA vs thrombectomy
More information5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016
Outpatient Stroke Management Sheila Smith MD May 5, 2016 1 Management of Outpatient Stroke Objectives Review blood pressure management post stroke Review antithrombotic therapy Review statin therapy Discuss
More informationKEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE OR TIA December 8, 2017
KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE OR TIA December 8, 2017 1 Faculty Disclosure Faculty: Grant Stotts MD, FRCPC Assistant Professor, uottawa Brain and Mind Institute
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationCarotid Revascularization
Options for Carotid Disease Carotid Revascularization Wayne Causey, MD 2 nd Year Vascular Surgery Fellow Best medical therapy, Carotid Endarterectomy, and Carotid Stenting Who benefits from best medical
More informationAntithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)
Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase
More informationPatent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS
Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS 11-8-18 Outline 1. Background 2. Anatomy of patent foramen ovale (PFO) 3. Relationship between PFO and
More informationStroke/TIA. Tom Bedwell
Stroke/TIA Tom Bedwell tab1g11@soton.ac.uk The Plan Definitions Anatomy Recap Aetiology Pathology Syndromes Brocas / Wernickes Investigations Management Prevention & Prognosis TIAs Key Definitions Transient
More informationSecondary Stroke Prevention: A Precautionary Tale
Secondary Stroke Prevention: A Precautionary Tale Kirsten George-Phillips, BSP Clinical Practice Leader, AHS Clinical Pharmacist, AHS Owen Stroke Prevention Clinic Learning Objectives! Examine literature
More informationNeuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute
Neuroanatomy of a Stroke Joni Clark, MD Professor of Neurology Barrow Neurologic Institute No disclosures Stroke case presentations Review signs and symptoms Review pertinent exam findings Identify the
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationCritical Review Form Therapy
Critical Review Form Therapy A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects, Lancet-Neurology 2007; 6: 953-960 Objectives: To evaluate the effect of
More informationEpisode 117 TIA Update
TIA Causes and Common Mimics Episode 117 TIA Update With Walter Himmel & David Dushenski Prepared by Shaun Mehta & Alex Hart, Nov 2018 Much has changed in recent years when it comes to TIA risk stratification,
More informationStroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian
Stroke in the ED Dr. William Whiteley Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian 2016 RCP Guideline for Stroke RCP guidelines for acute ischaemic stroke
More informationEmergently? Michigan Institute for Neurological Disorders. Garden City Hospital, Garden City, Michigan
Why Should TIA be Treated Emergently? Anne M. Pawlak, D.O. F.A.C.N. Michigan Institute for Neurological Disorders Director Neurology Residency Program, Garden City Hospital, Garden City, Michigan According
More informationMichael Horowitz, MD Pittsburgh, PA
Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion
More informationDisclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease
Disclosures Your Patient Has Carotid Bulb Stenosis and a Tandem Intracranial Stenosis: How Do SAMMPRIS and Other Evidence Inform Your Treatment? UCSF Vascular Symposium 2015 Steven W. Hetts, MD Associate
More informationSection Editor Scott E Kasner, MD
1 of 6 9/29/2013 6:55 PM Official reprint from UpToDate www.uptodate.com 2013 UpToDate The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis,
More information2018 Early Management of Acute Ischemic Stroke Guidelines Update
2018 Early Management of Acute Ischemic Stroke Guidelines Update Brandi Bowman, PhC, Pharm.D. April 17, 2018 Pharmacist Objectives Describe the recommendations for emergency medical services and hospital
More informationVague Neurological Conditions
Vague Neurological Conditions Dr. John Lefebre, MD, FRCPC Chief Regional Medical Director Europe, India, South Africa, Middle East and Turkey Canada 2014 2 3 4 Agenda Dr. John Lefebre, M.D., FRCPC 1. TIA
More informationOltre la terapia medica nelle dissezioni carotidee
Oltre la terapia medica nelle dissezioni carotidee Rodolfo Pini Chirurgia Vascolare Università di bologna Alma Mater Studiorum Carotid and Vertebral Artery Dissection What we know from the literature Epidemiology
More informationDocument Title: The Management of Acute Ischemic Stroke & TIA
Project: Ghana Emergency Medicine Collaborative Document Title: The Management of Acute Ischemic Stroke & TIA Author(s): Rashmi U. Kothari, M.D. (KCMS/MSU), 2012 License: Unless otherwise noted, this material
More informationNicolas Bianchi M.D. May 15th, 2012
Nicolas Bianchi M.D. May 15th, 2012 New concepts in TIA Differential Diagnosis Stroke Syndromes To learn the new definitions and concepts on TIA as a condition of high risk for stroke. To recognize the
More informationDr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre
Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre Objectives To learn what s new in stroke care 2010-11 1) Acute stroke management Carotid artery stenting versus surgery for symptomatic
More informationTIA Transient Ischaemic Attack?
TIA Transient Ischaemic Attack? OR Transient loss of function (TLOF) Tal Anjum Consultant Stroke Physician, Morriston Hospital Training & education lead, WASP (Welsh Association of Stroke Physicians) Qs.
More informationIt s Always a Stroke; Except For When It s Not..
It s Always a Stroke; Except For When It s Not.. TREVOR PHINNEY, D.O. Disclosures No Relevant Disclosures 1 Objectives Discuss variables of differential diagnosis for stroke Review when to TPA and when
More informationCryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare
Cryptogenic Stroke: What Don t We Know Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare Financial Disclosures None Objectives Principles of diagnostic evaluation
More informationTIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012
Charles Ashton Medical Director TIA AND STROKE Topics/Order of the day 1 What Works? Clinical features of TIA inc the difference between Carotid and Vertebral territories When is a TIA not a TIA TIA management
More informationCLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical
More information44TH ANNUAL RECENT ADVANCES IN NEUROLOGY
Presenter Disclosure Information J. Donald Easton, MD Clinical Professor of Neurology February 17, 2011 44TH ANNUAL RECENT ADVANCES IN NEUROLOGY TIA: Definition, Evaluation, and Treatment J. Donald Easton,
More informationCarotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO
Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent
More informationStroke Workshop. Pre-Workshop Handout. With Walter Himmel, Meeta Patel & Anton Helman
2018 Stroke Workshop Pre-Workshop Handout With Walter Himmel, Meeta Patel & Anton Helman Instructions for Getting the Most Out of The EMU Stroke Workshop Handout This workshop has been designed around
More informationHow to Evaluate Patients with Cryptogenic Stroke
How to Evaluate Patients with Cryptogenic Stroke Jeffrey Saver, MD Professor of Neurology Director, How to Evaluate Patients with Cryptogenic Stroke Disclosure Scientific Consultant, Unpaid Trialist: AGA
More informationGuiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology
Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology Ann M. Leonhardt Caprio, MS, RN, ANP-BC Program Coordinator Comprehensive Stroke Center, Strong Memorial Hospital Clinical
More informationStroke: What did we learn in the last year?
Stroke: What did we learn in the last year? J. Claude Hemphill III, MD, MAS Associate Professor of Clinical Neurology and Neurological Surgery University of California, San Francisco Director, Neurocritical
More informationND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014
ND STROKE Coordinators Case Studies STEMI and Stroke Conference, Fargo, ND, August 5, 2014 STROKE Coordinator Case Study Essentia Health, Fargo Essentia Health Stroke Alert Process Within 24 hours of Last
More informationCarotid Artery Stenting
Carotid Artery Stenting JESSICA MITCHELL, ACNP CENTRAL ILLINOIS RADIOLOGICAL ASSOCIATES External Carotid Artery (ECA) can easily be identified from Internal Carotid Artery (ICA) by noticing the branches.
More informationPost-op Carotid Complications A Nursing Perspective of What to Watch Out for
Post-op Carotid Complications A Nursing Perspective of What to Watch Out for By Kariss Peterson, ARNP Swedish Medical Center Inpatient Neurology Team 1 Post-op Carotid Management Objectives Review the
More informationAlan Barber. Professor of Clinical Neurology University of Auckland
Alan Barber Professor of Clinical Neurology University of Auckland Presented with Non-fluent dysphasia R facial weakness Background Ischaemic heart disease Hypertension Hyperlipidemia L MCA branch
More informationCerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11
Cerebrovascular Disorders Blood, Brain, and Energy 20% of body s oxygen usage No oxygen/glucose reserves Hypoxia - reduced oxygen Anoxia - Absence of oxygen supply Cell death can occur in as little as
More informationCanadian Stroke Best Practices Initial ED Evaluation of Acute Stroke and Transient Ischemic Attack (TIA) Order Set (Order Set 1)
Canadian Best Practice Recommendations for Stroke Care: All patients presenting to an emergency department with suspected stroke or transient ischemic attack must have an immediate clinical evaluation
More informationTCD in Subclavian Steal Syndrome
ISSN 2005-7881 Journal of Neurosonology 2(Suppl. 1):25-30, 2010 TCD in Subclavian Steal Syndrome Soon-Tae Lee, M.D., Ph.D. Department of Neurology, Seoul National University Hospital, Seoul, South Korea
More informationPractical Considerations in the Early Treatment of Acute Stroke
Practical Considerations in the Early Treatment of Acute Stroke Matthew E. Fink, MD Neurologist-in-Chief Weill Cornell Medical College New York-Presbyterian Hospital mfink@med.cornell.edu Disclosures Consultant
More informationNon ST Elevation-ACS. Michael W. Cammarata, MD
Non ST Elevation-ACS Michael W. Cammarata, MD Case Presentation 65 year old man PMH: CAD s/p stent in 2008 HTN HLD Presents with chest pressure, substernally and radiating to the left arm and jaw, similar
More informationGERIATRICS CASE PRESENTATION
GERIATRICS CASE PRESENTATION CASE 79 year old Patient X was admitted to hospital with SOB. He had a hx of sarcoidosis and asbestosis. Home oxygen requirement is 3-3.5litre. He was admitted, given ceftriaxone
More informationPharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development
STROKE Anne Kinnear Lead Pharmacist NHS Lothian Aim To update pharmacists on Stroke: the disease and its management and explore ways to implement pharmaceutical care for this patient group as part of normal
More informationStroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013
Stroke 101 Maine Cardiovascular Health Summit Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke Statistics Definition of stroke Risk factors Warning signs Treatment
More informationSymptoms of small vessel strokes. Small Vessel stroke. What is this? Treatment. Large Vessel stroke 6/1/2018
Stroke Stroke Megan Stevens MD Vascular Neurology SUDDEN Maximal at onset Lateralized weakness, lateralized numbness, vision loss (one eye or portion of field in both eyes), double vision, slurred speech,
More informationAnticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar
Anticoagulants and Head Injuries Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar Common Anticoagulants and Indications Coumadin (warfarin) indicated for
More informationSession Antiplatelet Therapy: How, Why and When? In patients with ischemic stroke/tia
GROUPE HOSPITALIER BICHAT-CLAUDE BERNARD PARIS DIDEROT UNIVERSITY - PARIS 7 Session Antiplatelet Therapy: How, Why and When? In patients with ischemic stroke/tia Pierre Amarenco INSERM U-698 and Denis
More informationInternal Carotid Artery Dissection
May 2011 Internal Carotid Artery Dissection Carolyn April, HMS IV Agenda Presentation of a clinical case Discussion of the clinical features of ICA dissection Discussion of the imaging modalities used
More informationENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist
ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist Pharmacy Grand Rounds 26 July 2016 2015 MFMER slide-1 Learning
More informationDepartment Specific Guideline
Department Specific Guideline Stroke/TIA Management ED Applicable to: Nursing/Medical staff caring Authorised by: Stroke services team for Acute stroke/tia patients Contact person: Clinical nurse manager,
More informationAdvances in the treatment of posterior cerebral circulation symptomatic disease
Advances in the treatment of posterior cerebral circulation symptomatic disease Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health
More informationMEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist
MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist neurointerventionist Steve Ramee, MD Ochsner Medical Center New Orleans DISCLOSURE Nothing Nothing to
More informationPrimary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:
When to Consider a Transfer: Hemorrhagic Stroke Large volume intracerebral hematoma greater than 5cm on CT Concern for expanding hematoma Rapidly declining mental status, especially requiring intubation
More informationTHE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease
THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation
More informationMD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one:
MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL 2014-15 The following is a list of variables and how to complete each one: (PHY-1) Case, per physician review: The most important task for the physicians
More informationBranko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center
Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center THE END! CHANGABLE Blood pressure Diabetes Mellitus Hyperlipidemia Atrial fibrillation Nicotine Drug abuse Life style NOT CHANGABLE
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationOverview INTRODUCTION 3/15/2018. Headache Emergencies. Other way to differentiate between them? Is there an easy way to differentiate between them?
Overview Headache Emergencies Primary versus Secondary headache disorder Red flags 4 cases of unusual headache emergencies Disclaimer: we will not talk about brain bleed as patients usually go the ED.
More informationEvaluation of the Dizzy Patient
Evaluation of the Dizzy Patient S. Andrew Josephson, MD Department of Neurology University of California San Francisco October 1, 2007 Who Sees Dizzy Patients? ED physicians Internists Neurologists ENT
More informationManagement of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis
Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Tim Mikesell, D.O. Oct 22, 2016 Stroke facts Despite progress in decreasing stroke incidence and mortality, stroke
More informationCarotid Stenosis 1/24/2019. Review of Primary Studies. NASCET- Moderate stenosis. ACAS (Asymptomatic Carotid Atherosclerosis Study) NASCET
Review of Primary Studies Carotid Stenosis NINDS National Institute of Neurological Disorders and Stroke 2 large studies to determine who would benefit from surgery NASCET North American Symptomatic Carotid
More informationOHSU HEALTH CARE SYSTEM PRACTICE GUIDELINES
OHSU HEALTH CARE SYSTEM NEUROSCIENCES (includes ischemic stroke, TIA, intracerebral hemorrhage and non-subarachnoid hemorrhage) Last Reviewed Date: September 2013 POLICY STATEMENT: OHSU hospitals and clinics
More informationLa terapia antiaggregante nel paziente con stroke
La terapia antiaggregante nel paziente con stroke Paolo Gresele Dipartimento di Medicina, Sez. Medicina Interna e Cardiovascolare Università di Perugia XXVII Congresso Nazionale FCSA Milano, 20-22 Ottobre
More informationManagement of cervicocephalic arterial dissection. Ciro G. Randazzo, MD, MPH Thomas Jefferson University Hospital, Department of Neurosurgery
Management of cervicocephalic arterial dissection Ciro G. Randazzo, MD, MPH Thomas Jefferson University Hospital, Department of Neurosurgery Definition Disruption of arterial wall, either at level of intima-media
More informationPermanent foramen ovale: when to close?
Permanent foramen ovale: when to close? Pierre Amarenco INSERM U-698 and Denis Diderot University - Paris VII Department of Neurology and Stroke Center Bichat hospital, Paris, France PFO - Pathology TEE
More informationBrain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center
Brain Attack Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship Stroke is a common and devastating disorder Third leading antecedent of death in American men, and second among
More information